香雪制药
(300147)
| 流通市值：62.85亿 | | | 总市值：63.22亿 |
| 流通股本：6.57亿 | | | 总股本：6.61亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 75,596,495.08 | 102,347,319.06 | 117,268,682.42 | 149,316,999.85 |
| 应收票据及应收账款 | 891,321,732.26 | 862,149,694.81 | 832,142,933.93 | 793,799,919.96 |
| 其中：应收票据 | 39,755,989.21 | 48,698,092.31 | 87,452,739.43 | 88,860,690.11 |
| 应收账款 | 851,565,743.05 | 813,451,602.5 | 744,690,194.5 | 704,939,229.85 |
| 应收款项融资 | - | 0 | - | 642,655 |
| 预付款项 | 21,630,243.75 | 21,781,780.37 | 27,206,027.5 | 24,548,829.37 |
| 其他应收款合计 | 64,912,933.35 | 59,551,484.82 | 51,784,275.66 | 52,546,660.13 |
| 应收股利 | 22,436,980.32 | 22,436,980.32 | 22,436,980.32 | 22,436,980.32 |
| 存货 | 420,980,343.45 | 462,581,095.69 | 407,603,150.37 | 411,297,654.94 |
| 其他流动资产 | 68,417,610.24 | 68,475,458.86 | 72,218,506.44 | 68,450,096.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,857,554,470.17 | 1,889,666,647.15 | 1,823,786,618.69 | 1,824,343,813.16 |
| 非流动资产: | | | | |
| 长期股权投资 | 33,918,508.98 | 34,033,246.73 | 44,177,382.04 | 43,706,227.84 |
| 其他权益工具投资 | 86,530,001 | 86,530,001 | 86,530,001 | 86,530,001 |
| 其他非流动金融资产 | 29,293,392.42 | 38,577,241.76 | 48,271,048.63 | 48,241,587.95 |
| 固定资产 | 3,249,372,409.1 | 3,278,382,895.23 | 3,321,537,896.72 | 3,369,354,400.44 |
| 在建工程 | 1,170,918,366.21 | 1,132,306,152.66 | 1,221,522,437.96 | 1,214,429,177.78 |
| 生产性生物资产 | 616,774.69 | 648,907.41 | 609,246.91 | 560,591.65 |
| 使用权资产 | 31,914,359.27 | 33,943,077.89 | 35,352,633.96 | 36,163,278.05 |
| 无形资产 | 851,894,372.37 | 868,694,662.04 | 907,423,581.81 | 919,283,146.51 |
| 开发支出 | 459,195,047.22 | 450,438,703.65 | 445,502,991.3 | 436,493,817.46 |
| 商誉 | 199,720,237.13 | 199,720,237.13 | 199,720,237.13 | 199,720,237.13 |
| 长期待摊费用 | 34,202,007.83 | 36,446,033.51 | 38,189,518.68 | 40,311,854.53 |
| 递延所得税资产 | 25,212,474.45 | 28,402,583.5 | 28,724,090.21 | 28,415,808.92 |
| 其他非流动资产 | 23,762,972.54 | 38,477,894.73 | 38,870,794.07 | 33,076,036.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,196,550,923.21 | 6,226,601,637.24 | 6,416,431,860.42 | 6,456,286,166.23 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,054,105,393.38 | 8,116,268,284.39 | 8,240,218,479.11 | 8,280,629,979.39 |
| 流动负债: | | | | |
| 短期借款 | 1,443,123,454.16 | 1,452,199,648.72 | 1,493,689,434.45 | 1,498,076,786.19 |
| 应付票据及应付账款 | 1,173,544,602.72 | 1,172,466,431.1 | 1,102,270,140.51 | 1,087,241,349.96 |
| 其中：应付票据 | 258,232.81 | 570,632.01 | 518,218.4 | 2,481,082.1 |
| 应付账款 | 1,173,286,369.91 | 1,171,895,799.09 | 1,101,751,922.11 | 1,084,760,267.86 |
| 预收款项 | - | 0 | 0 | 1,566,055.06 |
| 合同负债 | 151,945,439.6 | 138,983,600.26 | 138,301,649.74 | 161,239,421.84 |
| 应付职工薪酬 | 39,123,272.66 | 34,004,673.54 | 33,591,121.96 | 44,539,172.06 |
| 应交税费 | 53,115,021.59 | 50,286,156.5 | 66,659,502.69 | 70,626,896.09 |
| 其他应付款合计 | 1,945,204,553.96 | 1,934,547,958.98 | 1,867,082,470.9 | 1,862,556,670.93 |
| 其中:应付利息 | 71,508,685.81 | 41,035,028.72 | - | - |
| 应付股利 | - | - | - | 15,000,000 |
| 一年内到期的非流动负债 | 277,826,577.01 | 365,038,169.21 | 343,340,846.51 | 343,951,159.6 |
| 其他流动负债 | 41,117,485.08 | 45,246,146.76 | 77,635,452.47 | 65,676,263.88 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,156,548,087.13 | 5,224,100,930.42 | 5,152,530,199.12 | 5,161,681,554.89 |
| 非流动负债: | | | | |
| 长期借款 | 578,489,500 | 492,891,866.67 | 547,268,125.2 | 556,000,000 |
| 租赁负债 | 33,904,724.6 | 33,811,873.05 | 32,294,041.33 | 34,919,465.05 |
| 长期应付款 | 75,508,808.33 | 75,508,805.82 | 123,940,369.93 | 117,148,084.09 |
| 预计负债 | 23,094,164.13 | 27,427,679.65 | 28,776,338.94 | 27,776,535.39 |
| 递延收益 | 61,039,886.43 | 60,415,723.09 | 60,935,653.75 | 60,424,709.43 |
| 递延所得税负债 | 8,837,227.56 | 9,253,322.76 | 9,461,803.56 | 9,461,803.56 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 780,874,311.05 | 699,309,271.04 | 802,676,332.71 | 805,730,597.52 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 5,937,422,398.18 | 5,923,410,201.46 | 5,955,206,531.83 | 5,967,412,152.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 661,279,045 | 661,279,045 | 661,279,045 | 661,279,045 |
| 资本公积 | 2,152,290,476.39 | 2,152,290,476.39 | 2,152,290,476.39 | 2,152,290,476.39 |
| 减:库存股 | 8,500,866.64 | 8,500,866.64 | 8,500,866.64 | 8,500,866.64 |
| 其他综合收益 | 1,627,863.05 | 1,792,557.47 | 1,697,039.08 | 1,693,111.61 |
| 盈余公积 | 105,373,822.86 | 105,373,822.86 | 105,373,822.86 | 105,373,822.86 |
| 未分配利润 | -1,205,231,687.54 | -1,122,654,998.66 | -1,023,093,744.69 | -987,433,765.65 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,706,838,653.12 | 1,789,580,036.42 | 1,889,045,772 | 1,924,701,823.57 |
| 少数股东权益 | 409,844,342.08 | 403,278,046.51 | 395,966,175.28 | 388,516,003.41 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,116,682,995.2 | 2,192,858,082.93 | 2,285,011,947.28 | 2,313,217,826.98 |
| 负债和股东权益合计 | 8,054,105,393.38 | 8,116,268,284.39 | 8,240,218,479.11 | 8,280,629,979.39 |
| 公告日期 | 2024-10-26 | 2024-08-29 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 保留意见 |